| FDVKX | VVIAX | FDVKX / VVIAX | |
| Total Expense Ratio | 0.45 | 0.05 | 900% |
| Annual Report Gross Expense Ratio | 0.45 | 0.05 | 900% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | 4.478 | 13.974 | 32% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 216B | 0% |
| Annual Yield % from dividends | 1.81 | 2.04 | 89% |
| Returns for 1 year | 3.35 | 12.41 | 27% |
| Returns for 3 years | 8.41 | 37.41 | 22% |
| Returns for 5 years | 11.88 | 64.92 | 18% |
| Returns for 10 years | N/A | 133.33 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NEQCX | 12.64 | 0.02 | +0.16% |
| Neuberger U.S. Equity Impact C | |||
| OCSVX | 10.44 | N/A | N/A |
| Optimum Small-Mid Cap Value C | |||
| GRMSX | 30.89 | -0.01 | -0.03% |
| Nationwide S&P 500 Index Svc | |||
| CMGIX | 36.96 | -0.18 | -0.48% |
| BlackRock Mid-Cap Growth Equity Instl | |||
| BIPIX | 70.09 | -1.13 | -1.59% |
| ProFunds Biotechnology UltraSector Inv | |||